Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Equity Ratio: 2015-2025

Historic Equity Ratio for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to 0.07.

  • Editas Medicine's Equity Ratio fell 87.56% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year decrease of 87.56%. This contributed to the annual value of 0.39 for FY2024, which is 43.79% down from last year.
  • Per Editas Medicine's latest filing, its Equity Ratio stood at 0.07 for Q3 2025, which was down 26.82% from 0.09 recorded in Q2 2025.
  • Editas Medicine's 5-year Equity Ratio high stood at 0.82 for Q1 2022, and its period low was 0.07 during Q3 2025.
  • Over the past 3 years, Editas Medicine's median Equity Ratio value was 0.60 (recorded in 2024), while the average stood at 0.49.
  • As far as peak fluctuations go, Editas Medicine's Equity Ratio surged by 62.69% in 2021, and later plummeted by 87.56% in 2025.
  • Quarterly analysis of 5 years shows Editas Medicine's Equity Ratio stood at 0.82 in 2021, then declined by 14.19% to 0.70 in 2022, then dropped by 0.27% to 0.70 in 2023, then plummeted by 43.79% to 0.39 in 2024, then slumped by 87.56% to 0.07 in 2025.
  • Its Equity Ratio stands at 0.07 for Q3 2025, versus 0.09 for Q2 2025 and 0.24 for Q1 2025.